Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
4.800
+0.030 (0.63%)
Aug 15, 2025, 10:26 AM - Market open
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $56.58 million as of August 15, 2025. Its market cap has decreased by -14.46% in one year.
Market Cap
56.58M
Enterprise Value
23.78M
1-Year Change
-14.46%
Ranking
Category
Stock Price
$4.80
Market Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $56.58M, a decrease of -93.38%. That is a compound annual growth rate of -34.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 56.22M | 92.37% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | 437.69M | -37.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 614.44B |
| Johnson & Johnson | 420.78B |
| AbbVie | 361.58B |
| UnitedHealth Group | 245.88B |
| AstraZeneca | 243.29B |
| Novartis AG | 236.22B |
| Novo Nordisk | 225.09B |
| Abbott Laboratories | 225.01B |